Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Nasdaq

BMO Capital Maintains Market Perform Rating for Endo International: Here's What You Need To Know

BMO Capital has decided to maintain its Market Perform rating of Endo International (NASDAQ:ENDP) and lower its price target from $4.00 to $2.00. Shares of Endo International are trading down 14.79% over the last 24 hours, at $1.21 per share.

Benzinga

Morgan Stanley Maintains Overweight Rating for Warner Music Group: Here's What You Need To Know

Morgan Stanley has decided to maintain its Overweight rating of Warner Music Group (NASDAQ:WMG) and lower its price target from $50.00 to $40.00. Shares of Warner Music Group are trading down 4.05% over the last 24 hours, at $27.96 per share.

Benzinga

Stifel Maintains Hold Rating for Inogen: Here's What You Need To Know

Stifel has decided to maintain its Hold rating of Inogen (NASDAQ:INGN) and lower its price target from $40.00 to $30.00. Shares of Inogen are trading down 4.15% over the last 24 hours, at $23.91 per share. A move to $30.00 would account for a 25.5% increase from the current share…

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

Blac Chyna To Appeal Lawsuit Loss Against Kardashians, Faces Battery Accusation From Bar Fight

Model and reality television personality Blac Chyna is planning her next moves after losing her lawsuit against the Kardashians, but she is also under investigation for a physical altercation that occurred over the weekend.

Benzinga

4 Analysts Have This to Say About Playa Hotels & Resorts

Analysts have provided the following ratings for Playa Hotels & Resorts (NASDAQ:PLYA) within the last quarter:

Benzinga

RealNetworks Founder/CEO Robert Glaser Seeks To Buy Up All Outstanding Shares

RealNetworks Inc (NASDAQ: RNWK), a Seattle-based provider of artificial intelligence-based software and solutions, announced it received an unsolicited, non-binding proposal from Robert Glaser, the company’s founder, chairman and CEO, to acquire all of the outstanding shares

Benzinga

AEMD: Effectiveness of Hemopurifier on COVID-19 Variants In Vitro Indicates Device's Potential Range

By M. Marin NASDAQ:AEMD READ THE FULL AEMD RESEARCH REPORT

Benzinga

Read news from The Economist, FT, and more,
with one subscription

What Are Whales Doing With Micron Technology

Someone with a lot of money to spend has taken a bearish stance on Micron Technology (NASDAQ:MU). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

Benzinga

BZ Chart Of The Day: Is Apple About To Break Down?

Shares of Apple Inc. (NASDAQ: AAPL) may be breaking critical support. If they do, the stock may form a new downtrend.

Benzinga

Why Amazon Shares Are Falling

Shares of several companies in the broader tech sector, including Amazon.com, Inc. (NASDAQ: AMZN), are trading lower amid market weakness as traders continue to digest Wednesday’s Fed rate hike announcement. A gain in treasury yields has weighed on technology and growth stocks.

Benzinga

Why AMD Shares Are Diving Today

Shares of several companies in the broader tech sector, including Advanced Micro Devices, Inc. (NASDAQ: AMD), are trading lower amid market weakness as traders continue to digest Wednesday’s Fed rate hike announcement. A gain in treasury yields has weighed on technology and growth stocks.

Benzinga

Inspired Entertainment Earnings Preview

Inspired Entertainment (NASDAQ:INSE) is set to give its latest quarterly earnings report on Tuesday, 2022-05-10. Here's what investors need to know before the announcement. Analysts estimate that Inspired Entertainment will report an earnings per share (EPS) of $-0.08.

Benzinga

Halozyme Therapeutics's Earnings Outlook

Halozyme Therapeutics (NASDAQ:HALO) is set to give its latest quarterly earnings report on Tuesday, 2022-05-10. Here's what investors need to know before the announcement. Analysts estimate that Halozyme Therapeutics will report an earnings per share (EPS) of $0.49.

Benzinga

Tricida's Earnings: A Preview

Tricida (NASDAQ:TCDA) is set to give its latest quarterly earnings report on Tuesday, 2022-05-10. Here's what investors need to know before the announcement. Analysts estimate that Tricida will report an earnings per share (EPS) of $-0.70.

Benzinga

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Earnings Preview For Aurinia Pharmaceuticals

Aurinia Pharmaceuticals (NASDAQ:AUPH) is set to give its latest quarterly earnings report on Tuesday, 2022-05-10. Here's what investors need to know before the announcement. Analysts estimate that Aurinia Pharmaceuticals will report an earnings per share (EPS) of $-0.27.

Benzinga

Why Nvidia Shares Are Diving Today

Shares of several companies in the broader tech sector, including NVIDIA Corporation (NASDAQ: NVDA), are trading lower amid market weakness as traders continue to digest Wednesday’s Fed rate hike announcement. A gain in treasury yields has weighed on technology and growth stocks.

Benzinga

Why Microsoft Shares Are Falling Today

Shares of several companies in the broader tech sector, including Microsoft Corporation (NASDAQ: MSFT), are trading lower amid market weakness as traders continue to digest Wednesday’s Fed rate hike announcement. A gain in treasury yields has weighed on technology and growth stocks.

Benzinga

Earnings Outlook For Ebix

Ebix (NASDAQ:EBIX) is set to give its latest quarterly earnings report on Tuesday, 2022-05-10. Here's what investors need to know before the announcement. Analysts estimate that Ebix will report an earnings per share (EPS) of $0.55.

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

A Preview Of Collegium Pharmaceutical's Earnings

Collegium Pharmaceutical (NASDAQ:COLL) is set to give its latest quarterly earnings report on Tuesday, 2022-05-10. Here's what investors need to know before the announcement. Analysts estimate that Collegium Pharmaceutical will report an earnings per share (EPS) of $0.90.

Benzinga

Earnings Preview: Cleanspark

Cleanspark (NASDAQ:CLSK) is set to give its latest quarterly earnings report on Tuesday, 2022-05-10. Here's what investors need to know before the announcement. Analysts estimate that Cleanspark will report an earnings per share (EPS) of $0.30.

Benzinga

Earnings Preview For Purple Innovation

Purple Innovation (NASDAQ:PRPL) is set to give its latest quarterly earnings report on Tuesday, 2022-05-10. Here's what investors need to know before the announcement. Analysts estimate that Purple Innovation will report an earnings per share (EPS) of $-0.35.

Benzinga

Where Akoya Biosciences Stands With Analysts

Akoya Biosciences (NASDAQ:AKYA) has observed the following analyst ratings within the last quarter:

Benzinga

This Is What Whales Are Betting On Trade Desk

Someone with a lot of money to spend has taken a bearish stance on Trade Desk (NASDAQ:TTD). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

Benzinga

How Is The Market Feeling About AGNC Investment?

AGNC Investment's (NASDAQ:AGNC) short percent of float has risen 49.23% since its last report. The company recently reported that it has 24.95 million shares sold short, which is 4.82% of all regular shares that are available for trading.

Benzinga

Why Apple Shares Are Diving Today

Shares of several companies in the broader tech sector, including Apple Inc (NASDAQ: AAPL), are trading lower amid market weakness as traders continue to digest Wednesday’s Fed rate hike announcement. A gain in treasury yields has weighed on technology and growth stocks.

1 … 543 544 545 546

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Microsoft Corporation

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.